Placebo to match AZD8529

DRUG3 trials

Sponsors

AstraZeneca

Conditions

HealthyMemory ImpairmentSchizophrenia

Early Phase 1

The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

CompletedNCT00985933

AstraZenecaHealthy, Memory Impairment

Start: 2010-02-28End: 2011-04-30Target: 20Updated: 2011-05-04

Phase 1

The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics

CompletedNCT00986531

AstraZenecaSchizophrenia

Start: 2009-11-30End: 2011-10-31Updated: 2011-11-01

Phase 2

Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients

CompletedNCT00921804

AstraZenecaSchizophrenia

Start: 2009-06-30End: 2010-05-31Updated: 2010-06-30